Codon optimization reveals critical factors for high level expression of two rare codon genes in Escherichia coli: RNA stability and secondary structure but not tRNA abundance

Biochemical and Biophysical Research Communications
Xiaoqiu WuUdo Oppermann


Expression patterns in Escherichia coli of two small archaeal proteins with a natural content of about 30% rare codons were analyzed. The proteins, a histone-like protein from Sulfolobus shibatae (Ssh10), and a glutaredoxin-like protein from Methanobacterium thermoautotrophicum (mtGrx), were produced with expression plasmids encoding wild-type genes, codon-optimized synthetic, and GST-fusion genes. These constructs were expressed in BL21 (DE3), its LysS derivative, and modified strains carrying copies for rare codon tRNAs or deletions in the RNAseE gene. Both Ssh10 and mtGrx expression levels were constitutively high in BL21(DE3) and its derivatives, with the exception of the LysS phenotype, which prevented high level expression of the Ssh10 wild-type gene. Surprisingly, a codon-optimized mtGrx gene construct displayed undetectable levels of protein production. The translational block observed with the synthetic mtGrx gene could be circumvented by using a synthetic mtGrx-glutathione S-transferase (GST) fusion construct or by in vitro translation. Taken together, the results underscore the importance of mRNA levels and RNA stability, but not necessarily tRNA abundance for efficient heterologous protein production in E. coli.


May 11, 1992·Nucleic Acids Research·K WadaT Ikemura
May 1, 1990·Molecular and Cellular Biology·D HerrickA Jacobson
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R A Spanjaard, J van Duin
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J Sipley, E Goldman
Dec 2, 1996·Molecular and Biochemical Parasitology·P PrapunwattanaD V Santi
Mar 7, 1998·Structure·D R CasimiroH J Dyson
Mar 6, 1998·Trends in Biotechnology·G Hannig, S C Makrides
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·L Duret, D Mouchiroud
Jul 17, 1999·Biochimica Et Biophysica Acta·M F Alexeyev, H H Winkler
Oct 6, 1999·Current Opinion in Biotechnology·F Baneyx
Apr 5, 2001·Current Opinion in Biotechnology·J R Swartz
Feb 25, 2003·Protein Expression and Purification·Dean E McNultyJames F Kane
Mar 26, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Xiaoqiu Wu, Udo Oppermann

❮ Previous
Next ❯


Oct 12, 2012·Bioprocess and Biosystems Engineering·Soojin LeeJinwon Lee
Mar 31, 2009·Biotechnology Letters·Sampali BanerjeeSriram Padmanabhan
Jan 12, 2011·Molecular Biotechnology·Charles GauciMarshall W Lightowlers
Aug 21, 2013·Molecular Biotechnology·Giulia GiannuzziCarlo M T Marobbio
Oct 7, 2009·Journal of Biosciences·Sarbashis DasAlok Bhattacharya
Feb 10, 2010·Tissue Engineering. Part B, Reviews·Debanti Sengupta, Sarah C Heilshorn
Oct 26, 2006·Nucleic Acids Research·Gang WuStephen J Freeland
Sep 16, 2008·Applied and Environmental Microbiology·Masafumi TokuokaKatsuya Gomi
Jun 1, 2007·BMC Biotechnology·Brian C GeyerTsafrir S Mor
May 17, 2011·Microbial Cell Factories·Tomohiro MakinoGeorge Georgiou
Jan 1, 2011·Microbial Informatics and Experimentation·W Nicholson PriceJohn F Hunt
Jan 7, 2005·Applied Microbiology and Biotechnology·S Jana, J K Deb
Sep 30, 2014·Trends in Molecular Medicine·Vincent P Mauro, Stephen A Chappell
Jun 1, 2014·Applied Microbiology and Biotechnology·Michaela OsadskáJán Turňa
Dec 27, 2011·Journal of Bioscience and Bioengineering·Kayo OhkouchiKazuhisa Ono
Jul 28, 2011·Vaccine·Abolfazl JahangiriSaeed Khalili
Feb 8, 2011·Protein Expression and Purification·Filip M GolebiowskiMarta Dziedzicka-Wasylewska
Jan 22, 2008·Journal of Biotechnology·Pernille Ollendorff MicheelsenMichael Skjøt
May 9, 2007·Protein Expression and Purification·Dequan ChenAlbert O Edwards
Dec 21, 2004·Journal of Biotechnology·Hans Peter Sørensen, Kim Kusk Mortensen
Jul 13, 2004·Trends in Biotechnology·Claes GustafssonJeremy Minshull
Sep 12, 2006·Protein Expression and Purification·Seonghun Kim, Sun Bok Lee
Aug 26, 2006·Biochemical and Biophysical Research Communications·Weici ZhangZhigang Tian
Dec 27, 2005·Protein Expression and Purification·Gang WuStephen J Freeland
Mar 31, 2015·The International Journal of Biochemistry & Cell Biology·Vedrana Bali, Zsuzsanna Bebok
May 6, 2015·Journal of Theoretical Biology·Saeed KhaliliAbolfazl Jahangiri
Feb 22, 2008·Protein Expression and Purification·Nicola A Burgess-BrownOpher Gileadi
Mar 20, 2012·Protein Expression and Purification·Claes GustafssonMark Welch
Dec 7, 2010·Biochimie·Manuel Montalbán-LópezMercedes Maqueda
Jan 24, 2007·Biochemical and Biophysical Research Communications·Bingli WuWuju Li
Dec 3, 2014·Biochemical and Biophysical Research Communications·Jun YinWenbing Yao
Oct 31, 2014·PLoS Computational Biology·Sophia RudorfReinhard Lipowsky
Mar 20, 2012·PloS One·Ajith Harish, Gustavo Caetano-Anollés
Jul 26, 2012·PLoS Genetics·Roman HäuserPeter Uetz
Nov 8, 2012·PLoS Computational Biology·Samuel M D SeaverLuís A Nunes Amaral
Sep 17, 2013·PloS One·Marlena Siwiak, Piotr Zielenkiewicz
Apr 6, 2012·PLoS Genetics·Wenfeng QianJianzhi Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.